Allergy Therapeutics plc specializes in the development and commercialization of allergen immunotherapy products aimed at treating allergies by addressing their underlying causes rather than merely alleviating symptoms. The company offers both subcutaneous and sublingual immunotherapy treatments for various allergens, including pollen and peanuts. Its primary markets include Germany, Spain, and Austria, where it generates revenue through the sale of its immunotherapy products. Allergy Therapeutics is focused on advancing its research and development pipeline to enhance patient care in allergy treatment.
Allergy Therapeutics plc specializes in the development and commercialization of allergen immunotherapy products aimed at treating allergies by addressing their underlying causes rather than merely alleviating symptoms. The company offers both subcutaneous and sublingual immunotherapy treatments for various allergens, including pollen and peanuts. Its primary markets include Germany, Spain, and Austria, where it generates revenue through the sale of its immunotherapy products. Allergy Therapeutics is focused on advancing its research and development pipeline to enhance patient care in allergy treatment.
